Channing Hamlet

Channing Hamlet is a Managing Director with Objective, Investment Banking & Valuation, where he serves as an execution leader for the firm's M&A and Valuation Groups and heads its Life Sciences Services & Tech and Business Services practices. He brings more than 25 years of experience in investment banking and business valuation, and has personally closed 25+ sell-side transactions over the past five years, advising business owners through complex exits and recapitalizations.

Before Objective, Hamlet was a Managing Director at Cabrillo Advisors, where he led M&A execution and grew the firm's valuation practice from inception into a national operation serving more than 700 clients within five years. Earlier in his career he served as a Director at Vistage (the executive peer-advisory organization), as a Principal at LLR Partners — a private-equity firm then managing roughly $260 million — and as a member of Legg Mason's Investment Banking group.

Hamlet earned both his degrees from Cornell University: a Master's in Operations Research and a Bachelor of Science in Mechanical Engineering. He holds FINRA Series 7, 63, and 79 licenses and is a Registered Representative of BA Securities, LLC (Member FINRA/SIPC). He is active in the professional community through the Association for Corporate Growth (Los Angeles, membership committee), ProVisors (group leader), and philanthropic work with organizations including Reality Changers.

Objective, Investment Banking & Valuation, founded in 2006, positions itself as a leading advisor to the lower middle market, with principals having collectively engaged in more than 500 successful transactions.

• Advisory, not equity investing: Hamlet's "deals" are sell-side M&A engagements and valuations, not equity checks written into startups. He represents owners selling or recapitalizing their companies.
• Deal size / market: Lower middle market — enterprise values of roughly $20–$75 million, serving companies with revenues up to about $500 million.
• Sector concentration: Deep specialization in Life Sciences Services & Tech (e.g., life-sciences executive search, data-management solutions) and Business Services.
• Value framing: Much of his public thought leadership centers on the question "What's your business really worth?" — helping owners understand valuation drivers and maximize enterprise value ahead of a transaction.